SPOTLIGHT: Ventana inks buyout deal

Ventana Medical Systems, which has been fighting a takeover offer from Roche, has inked a deal to acquire Spring BioScience--which makes rabbit monoclonal antibodies and other reagents--for $28.9 million. Spring investors also stand to gain up to $11.7 million in milestones. Report

Suggested Articles

Genor Biopharma banked $160 million from the likes of Hillhouse and Temasek Holdings to advance its clinical-stage autoimmune and cancer programs.

Going from being the CSO of Bristol Myers Squibb to running one of the biggest cancer research organizations in the world is a major career shift.

Hahn made the commitment in a speech that called on the FDA to learn from the crisis to enact lasting policies that accelerate drug development.